And as the authors further noted, The therapeutic scope of GLP-1 medicines extends beyond glycemic control and weight loss, with benefits evident in people with atherosclerotic heart disease, heart failure with preserved ejection fraction (HFpEF), peripheral artery disease, diabetic kidney disease, knee osteoarthritis, and obstructive sleep apnea (OSA). However, as the team further pointed out, the mechanisms by which GLP-1 medicines improve organ dysfunction remain incompletely understood. Drucker has been at the forefront of GLP-1 research since the 1980s when his pioneering discoveries helped lay the groundwork for the development of GLP-1 medicines
I n skeletal muscle, IGF1R activation sensitizes IRS1 to degradation, and a screen for the responsible E3 ligase identified Fbxo40 as mediating this rapid turnover of IRS1, since IRS1 loss can be rescued by knockdown of Fbxo40
(Berl.) 95 , 323333
was supported by the German Research Foundation (DFG) KN1148/4-1 and Project-ID 394046635, SFB 1365
The copper ion participates in superoxide dismutase (SOD)-like activity